PCa	Prostate Cancer
PSMA-D4	Prostate-Specific Membrane Antigen ligand conjugated with DOTA (Glu-CO-Lys-L-Trp-4-Amc-DOTA)
DOTA	1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, tetraxetan
mCRPC	metastatic castration-resistant prostate cancer
PSA	prostate-specific antigen
GCPII	glutamate carboxypeptidase II
BFC	bifunctional chelator
LNCaP	Lymph Node Carcinoma of the Prostate
COMU	1-[(1-(cyano-2-ethoxy-2-oxoethylideneaminooxy)dimethylaminemorpholino)]uronium hexafluorophosphate
KD	binging affinity
Bmax	maximum receptor density
CLI	Cerenkov luminescence imaging
ROI	region of interest
SA	specific activity
RCY	radiochemical yield
ATCC	American Type Culture Collection
FBS	fetal bovine serum
ID	injected dose
SD	standard deviation
SE	electrospray soure
IT	ion trap
TOF	time of flight analyzer
TCD	Thermal conductivity detector